首页> 外文期刊>Pathology case reviews. >Micrometastases In Sentinel Lymph Node Biopsies:The Medical Oncologist's Perspective: To Treat Or Not To Treat?
【24h】

Micrometastases In Sentinel Lymph Node Biopsies:The Medical Oncologist's Perspective: To Treat Or Not To Treat?

机译:前哨淋巴结活检中的微转移:肿瘤内科医生的观点:治疗还是不治疗?

获取原文
获取原文并翻译 | 示例
           

摘要

Sentitle lymph node biopsies (SLNB) are changing the management of patients with breast cancer. Although SLNB result in less morbidity than level I and II dissections, equivalence of long-term survival results should not be assumed. Micrometastases as defined by American Joint Committee, on Cancer (AJCC) staging criteria appear to be : an adverse prognostic factor and are now being used in practice to identify patients with invasive cancer who should receive adjuvant therapy. Based on present di^a, isolated cancer cells or srrjall clusters should be disregarded when making recommendations about adjuvant systemic therapy.
机译:Sentitle淋巴结活检(SLNB)正在改变乳腺癌患者的治疗。尽管SLNB的发病率低于I和II级解剖,但不应假定等效的长期生存结果。由美国癌症联合委员会(AJCC)分期标准定义的微转移似乎是:不良预后因素,目前已在实践中用于鉴定应接受辅助治疗的浸润性癌症患者。根据目前的情况,在提出有关辅助全身治疗的建议时,应忽略孤立的癌细胞或srrjall簇。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号